Insights Into Congenital Lymphatic Anomalies Underlying Fetal Effusions
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Sara G Vargo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Lymphatic Abnormalities, Lymphedema, Fetal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
We describe a series of pregnancies with autosomal dominant lymphedema and generalized lymphatic dysplasia in the fetus diagnosed with prenatal exome or genome sequencing. We focus on specific syndromes, fetal features, and parental symptoms to deepen our understanding of congenital lymphatic anomalies.
Methods
Pregnancies with one or more fetal effusions were prospectively enrolled from 2017 to 2024 and underwent exome or genome sequencing. Fetal effusions included increased nuchal translucency ≥ 3.5 mm, cystic hygroma, pleural effusion, pericardial effusion, ascites, and/or skin edema. Records were reviewed to extract personal and family history, ultrasound findings, and pregnancy outcomes.
Results
Among 303 pregnancies with one or more fetal effusions, eight (3%) had a molecular diagnosis of autosomal dominant lymphedema or generalized lymphatic dysplasia. Gestational age at detection of fetal effusion(s) ranged from the first through third trimesters. Four fetuses inherited the genetic variant(s) from a biological parent. Of these, one parent was asymptomatic, and three had largely milder symptoms than their fetus. Perinatal outcomes were more favorable for fetuses with heterozygous PIEZO1 variants.
Conclusion
Autosomal dominant lymphedema and generalized lymphatic dysplasia can present with a breadth of fetal effusions from the first through third trimesters and are frequently inherited from a biological parent with less severe symptoms. These data provide a deeper understanding of how congenital lymphatic anomalies manifest in utero and inform expectations about recurrence risk in future pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, University of California, San Francisco, California, USA.
- Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Diego, California, USA.
- Genomic Medicine Laboratory, University of California, San Francisco, California, USA.
- Institute for Human Genetics, University of California, San Francisco, California, USA.
- Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco, California, USA.
ORCID-Profile: Sara G Vargo, Daniella Rogerson, Teresa N Sparks
Förderung
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Vargo, S. G., Rogerson, D., Devine, P., Van Ziffle, J., & Sparks, T. N. (2026). Insights Into Congenital Lymphatic Anomalies Underlying Fetal Effusions. Prenatal Diagnosis. https://doi.org/10.1002/pd.70016
Vancouver
Vargo SG, Rogerson D, Devine P, Van Ziffle J, Sparks TN. Insights Into Congenital Lymphatic Anomalies Underlying Fetal Effusions. Prenatal Diagnosis. 2026. doi:10.1002/pd.70016
BibTeX
@article{Vargo2026,
author = {Vargo, Sara G and Rogerson, Daniella and Devine, Patrick and Van Ziffle, Jessica and Sparks, Teresa N},
title = {Insights Into Congenital Lymphatic Anomalies Underlying Fetal Effusions},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70016}
}
EUVIMED